Prevalence of Antibodies to Crimean-Congo Hemorrhagic Fever Virus in Ruminants, Nigeria, 2015
Daniel Oluwayelu
1 , Babak Afrough
1, Adebowale Adebiyi, Anitha Varghese, Park Eun-Sil, Shuetsu Fukushi, Tomoki Yoshikawa, Masayuki Saijo, Eric Neumann, Shigeru Morikawa, Roger Hewson, and Oyewale Tomori
Author affiliations: University of Ibadan, Ibadan, Nigeria (D. Oluwayelu, A. Adebiyi); Public Health England, Salisbury, UK (B. Afrough, A. Varghese, R. Hewson); National Institute of Infectious Diseases, Shinjuku, Tokyo, Japan (P. Eun-Sil, S. Fukushi, T. Yoshikawa, M. Saijo, S. Morikawa); Massey University, Palmerston North, New Zealand (E. Neumann); Nigerian Academy of Science, Yaba, Nigeria (O. Tomori)
Main Article
Figure 2
Figure 2. Prevalence of antibodies to Crimean-Congo hemorrhagic fever virus (CCHFV) in ruminants, Nigeria, 2015. A) Distribution of ELISA OD values for serum samples from cattle according to indirect fluorescent antibody test (IFAT) results, Nigeria. The OD at 405 nm for each serum sample at a dilution of 1:400 in the ELISA was plotted against serum samples from CCHFV IFAT antibody-positive and antibody-negative cattle. Three antibody-negative samples (open circles) were above the cutoff OD value in the ELISA and thus considered to be false positive in the ELISA. Other antibody-negative samples (solid circles) were also ELISA negative. Horizontal bars indicate mean OD values. Solid squares indicate IFAT-positive serum samples. B) Receiver operating characteristic (ROC) analysis of an IgG-ELISA specific for nucleoprotein of CCHFV. Area under the ROC curve was 0.9762, which indicates that the test has a good probability of distinguishing between CCHFV antibody–positive and –negative cattle. OD, optical density.
Main Article
Page created: March 17, 2020
Page updated: March 17, 2020
Page reviewed: March 17, 2020
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.